Effects of nitric oxide releasing poly(vinyl alcohol) hydrogel dressings on dermal wound healing in diabetic mice

Healing of chronic wounds such as diabetic foot ulcers is a significant clinical problem. Methods of accelerating healing in these difficult lower extremity sites include use of growth factor–loaded gels, hyperbaric oxygen, grafts, and artificial skin replacements. Nitric oxide (NO) has been proposed as a possible active agent for enhancing wound healing. This study examines the in vitro and in vivo responses to a novel hydrogel that produces therapeutic levels of NO. A hydrogel wound dressing was fabricated using ultraviolet light‐initiated polymerization from poly(vinyl alcohol) with a NO donor covalently coupled to the polymer backbone. NO release from the NO‐modified hydrogel was shown to occur over a time period of up to 48 hours, and there was no associated decrease in fibroblast growth or viability in vitro associated with NO hydrogels. Fibroblasts in culture with NO hydrogels had an increased production of extracellular matrix compared with cells cultured without the NO hydrogels. Preliminary animal studies in a diabetic mouse, impaired wound healing model were conducted comparing low (0.5 mM) and high (5 mM) doses of NO. Time to complete closure was similar in control wounds and NO‐treated wounds; however, at 8 days control wounds were significantly smaller than NO‐treated wounds. By days 10 to 13 this delay was no longer apparent. Granulation tissue thickness within the wounds at days 8 and 15 and scar tissue thickness after wound closure were increased in animals exposed to higher dose NO hydrogels. The results of this study suggest that exogenous NO released from a hydrogel wound dressing has potential to modulate wound healing. (WOUND REP REG 2002;10:286–294)

[1]  L. Moldawer,et al.  Enhanced collagen accumulation following direct transfection of the inducible nitric oxide synthase gene in cutaneous wounds. , 1998, Biochemical and biophysical research communications.

[2]  Timothy R Billiar,et al.  Impaired wound healing and angiogenesis in eNOS-deficient mice. , 1999, American journal of physiology. Heart and circulatory physiology.

[3]  K. M. Davies,et al.  Chemistry of the diazeniumdiolates. 2. Kinetics and mechanism of dissociation to nitric oxide in aqueous solution. , 2001, Journal of the American Chemical Society.

[4]  M. Robson.  The role of growth factors in the healing of chronic wounds , 1997, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[5]  S. Moore.  Amino acid analysis: aqueous dimethyl sulfoxide as solvent for the ninhydrin reaction. , 1968, The Journal of biological chemistry.

[6]  D. Steed,et al.  Reversal of impaired wound repair in iNOS-deficient mice by topical adenoviral-mediated iNOS gene transfer. , 1998, The Journal of clinical investigation.

[7]  U. Tantry,et al.  Nitric oxide metabolism in wounds. , 1997, The Journal of surgical research.

[8]  J L West,et al.  Nitric oxide-generating polymers reduce platelet adhesion and smooth muscle cell proliferation. , 2000, Biomaterials.

[9]  D. Wink,et al.  Complexes of .NO with nucleophiles as agents for the controlled biological release of nitric oxide. Vasorelaxant effects. , 1991, Journal of medicinal chemistry.

[10]  C. George,et al.  Chemistry of the diazeniumdiolates. I. Structural and spectral characteristics of the [N(O)NO]- functional group. , 2001, Nitric oxide : biology and chemistry.

[11]  U. Tantry,et al.  Supplemental dietary arginine enhances wound healing in normal but not inducible nitric oxide synthase knockout mice. , 2000, Surgery.

[12]  J. Pfeilschifter,et al.  Keratinocyte-derived chemotactic cytokines: expressional modulation by nitric oxide in vitro and during cutaneous wound repair in vivo. , 2000, Biochemical and biophysical research communications.

[13]  U. Tantry,et al.  Nitric oxide regulates wound healing. , 1996, The Journal of surgical research.

[14]  D. Laskin,et al.  Epidermal growth factor suppresses nitric oxide and hydrogen peroxide production by keratinocytes. Potential role for nitric oxide in the regulation of wound healing. , 1992, The Journal of biological chemistry.

[15]  D. Wink,et al.  Colorimetric assays for nitric oxide and nitrogen oxide species formed from nitric oxide stock solutions and donor compounds. , 1996, Methods in enzymology.

[16]  P. Efron,et al.  Diabetes-impaired healing and reduced wound nitric oxide synthesis: a possible pathophysiologic correlation. , 1997, Surgery.

[17]  J. García-Alonso,et al.  Randomized single-blind trial of topical ketanserin for healing acceleration of diabetic foot ulcers. , 1997, Archives of medical research.

[18]  S. Leibovich,et al.  Production of vascular endothelial growth factor by murine macrophages: regulation by hypoxia, lactate, and the inducible nitric oxide synthase pathway. , 1998, The American journal of pathology.

[19]  R. Prior,et al.  Sample pretreatment with nitrate reductase and glucose-6-phosphate dehydrogenase quantitatively reduces nitrate while avoiding interference by NADP+ when the Griess reaction is used to assay for nitrite. , 1995, Analytical biochemistry.

[20]  Robson Mc,et al.  The role of growth factors in the healing of chronic wounds , 1997, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[21]  A. Johnston,et al.  A novel method for the delivery of nitric oxide therapy to the skin of human subjects using a semi-permeable membrane. , 2001, Clinical science.

[22]  J. West,et al.  Modification of surfaces with cell adhesion peptides alters extracellular matrix deposition. , 1999, Biomaterials.

[23]  T. Wieman.  Clinical efficacy of becaplermin (rhPDGF-BB) gel , 1998 .

[24]  A. Butler,et al.  Chemistry, analysis, and biological roles of S-nitrosothiols. , 1997, Analytical biochemistry.

[25]  P. Efron,et al.  Nitric oxide, an autocrine regulator of wound fibroblast synthetic function. , 1997, Journal of immunology.

[26]  J. Pfeilschifter,et al.  The function of nitric oxide in wound repair: inhibition of inducible nitric oxide-synthase severely impairs wound reepithelialization. , 1999, The Journal of investigative dermatology.

[27]  E. LeGrand.  Preclinical promise of becaplermin (rhPDGF-BB) in wound healing. , 1998, American journal of surgery.

[28]  C. Suschek,et al.  Biphasic effect of exogenous nitric oxide on proliferation and differentiation in skin derived keratinocytes but not fibroblasts. , 1998, The Journal of investigative dermatology.

[29]  J. Boykin.  The nitric oxide connection: hyperbaric oxygen therapy, becaplermin, and diabetic ulcer management. , 2000, Advances in skin & wound care.

[30]  J. Pfeilschifter,et al.  Nitric oxide triggers enhanced induction of vascular endothelial growth factor expression in cultured keratinocytes (HaCaT) and during cutaneous wound repair , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[31]  D. Smith,et al.  Evaluation of linear polyethyleneimine/nitric oxide adduct on wound repair: therapy versus toxicity , 1998, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.